SARS-CoV-2

Potential benefits of delaying the second mRNA COVID-19 vaccine dose

Vaccination against COVID-19 with the recently approved mRNA vaccines BNT162b2 (BioNTech/Pfizer) and mRNA-1273 (Moderna) is currently underway in a large number of countries. However, high incidence rates and rapidly spreading SARS-CoV-2 variants are …

German COVID-19 Snapshot Monitoring (COSMO)-Welle 11 (12.05.2020)

Risk perceptions down at pre-lockdown level, acceptance of measures related to worries aboutindividual economic situationRisk perceptions are still declining, as is the acceptance of the measures;both dropping to the before-lockdown level. 89% keep a …

Coronavirus-Pandemie--Die Krise nachhaltig überwinden

Die Ausbreitung des SARS-CoV-2-Virus hat inzwischen auf alle Bereiche unserer Gesellschaft massive Auswirkungen. Angesichts der daraus resultierenden enormen Unsicherheit kommt der Wissenschaft eine große Verantwortung zu. Sie muss auf der Basis …

Effective containment explains subexponential growth in recent confirmed COVID-19 cases in China

The recent outbreak of coronavirus disease 2019 (COVID-19) in mainland China was characterized by a distinctive subexponential increase of confirmed cases during the early phase of the epidemic, contrasting with an initial exponential growth expected …